WallStreetZenWallStreetZen

NASDAQ: LIPO
Lipella Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LIPO past revenue growth

How has LIPO's revenue growth performed historically?
Company
144.15%
Industry
148.64%
Market
17.33%
LIPO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LIPO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LIPO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LIPO earnings and revenue history

Current Revenue
$449.6k
Current Earnings
-$4.6M
Current Profit Margin
-1,027.3%

LIPO Return on Equity

Current Company
-150.1%
Current Industry
-63.5%
Current Market
188%
LIPO's Return on Equity (-150.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LIPO announces earnings.

LIPO Return on Assets

Current Company
-127.2%
Current Industry
2.9%
LIPO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LIPO Return on Capital Employed

Current Company
-144.37%
Current Industry
19.5%
LIPO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LIPO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LIPO$449.62k-$4.61M-$4.62M-81.05%N/A
SEEL$2.20M-$37.75M-$37.88M+55.68%N/A
FNCH$107.00k-$75.60M-$74.75M-67.96%N/A
THAR$0.00-$9.30M-$9.32MN/AN/A
GNPX$0.00-$30.85M-$30.86MN/AN/A
View Top Biotech Stocks

Lipella Pharmaceuticals Earnings & Revenue FAQ

What were LIPO's earnings last quarter?

Lipella Pharmaceuticals (NASDAQ: LIPO) reported Q4 2023 earnings per share (EPS) of -$0.09, up 28.57% year over year. Total Lipella Pharmaceuticals earnings for the quarter were -$688.88 thousand. In the same quarter last year, Lipella Pharmaceuticals's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Lipella Pharmaceuticals stock.

What was LIPO's earnings growth in the past year?

As of Q2 2024, Lipella Pharmaceuticals's earnings has grown year over year. Lipella Pharmaceuticals's earnings in the past year totalled -$4.62 million.

What was LIPO's revenue last quarter?

Lipella Pharmaceuticals (NASDAQ: LIPO) reported Q4 2023 revenue of $120.84 thousand up 19.98% year over year. In the same quarter last year, Lipella Pharmaceuticals's revenue was $151.01 thousand.

What was LIPO's revenue growth in the past year?

As of Q2 2024, Lipella Pharmaceuticals's revenue has grown 144.15% year over year. This is 4.49 percentage points lower than the US Biotechnology industry revenue growth rate of 148.64%. Lipella Pharmaceuticals's revenue in the past year totalled $449.62 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.